• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,503.60 -1,677.12
( -2.15%)
Global Indices
Nasdaq
52,927.94 -148.97
(-0.28%)
Dow Jones
7,522.05 -36.38
(-0.48%)
Hang Seng
67,213.51 -1,043.45
(-1.53%)
Nikkei 225
10,469.05 -196.83
(-1.85%)
Forex
USD-INR
95.36 0.17
(0.18%)
EUR-INR
108.98 0.13
(0.12%)
GBP-INR
127.38 0.36
(0.28%)
JPY-INR
0.59 0.00
(-0.24%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
276.4035981
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
37.2
919.15
EPS(TTM)
Face Value()
Div & Yield %
20.97
10
0.06
 

srestha finvest ltd
State Bank of India ends higher after board OKs proposa to raise Rs 60,000 crore
Jun 18,2026

The fundraising may be undertaken through one or more instruments, including long-term bonds, Basel III-compliant Additional Tier 1 (AT1) bonds and Basel III-compliant Tier 2 bonds, via public issuances and/or private placements to domestic and overseas investors.

State Bank of India is India’s largest public sector lender with operations across retail banking, corporate banking, treasury, international banking and financial services.

The bank’s net profit stood at Rs 19,684 crore in Q4 FY26, up 5.58% year-on-year but down 6.39% sequentially. Total income stood at Rs 1,40,412 crore, down 2.41% YoY and marginally lower on a sequential basis.